Home LiteratureArticle Details
PMID: 16687478 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients.

Smith EE, Buckley DG, Wu Z, Saenphimmachak C, Hoffman LR, D'Argenio DA, Miller SI, Ramsey BW, Speert DP, Moskowitz SM, Burns JL, Kaul R, Olson MV

Abstract

In many human infections, hosts and pathogens coexist for years or decades. Important examples include HIV, herpes viruses, tuberculosis, leprosy, and malaria. With the exception of intensively studied viral infections such as HIV/AIDs, little is known about the extent to which the clonal expansion that occurs during long-term infection by pathogens involves important genetic adaptations. We report here a detailed, whole-genome analysis of one such infection, that of a cystic fibrosis (CF) patient by the opportunistic bacterial pathogen Pseudomonas aeruginosa. The bacteria underwent numerous genetic adaptations during 8 years of infection, as evidenced by a positive-selection signal across the genome and an overwhelming signal in specific genes, several of which are mutated during the course of most CF infections. Of particular interest is our finding that virulence factors that are required for the initiation of acute infections are often selected against during chronic infections. It is apparent that the genotypes of the P. aeruginosa strains present in advanced CF infections differ systematically from those of "wild-type" P. aeruginosa and that these differences may offer new opportunities for treatment of this chronic disease.

MeSH Terms
Adaptation, Physiological/genetics Bacterial Proteins/genetics Chronic Disease Cystic Fibrosis/complications,microbiology,pathology DNA-Binding Proteins/genetics Genome, Bacterial/genetics Humans Molecular Sequence Data Mutation/genetics Pseudomonas Infections/complications,microbiology,pathology Pseudomonas aeruginosa/genetics,isolation & purification,physiology Selection, Genetic Time Factors Trans-Activators/genetics
Chemicals
Bacterial Proteins DNA-Binding Proteins LasR protein, Pseudomonas aeruginosa MexZ protein, Pseudomonas aeruginosa Trans-Activators
Authors & Affiliations
13 authors, click to expand affiliations / ORCID
Smith Eric E
Genome Center, Program in Molecular and Cellular Biology, University of Washington, Seattle, WA 98195, USA. [email protected]
Buckley Danielle G
Wu Zaining
Saenphimmachak Channakhone
Hoffman Lucas R
D'Argenio David A
Miller Samuel I
Ramsey Bonnie W
Speert David P
Moskowitz Samuel M
Burns Jane L
Kaul Rajinder
Olson Maynard V
References (38)
38 references, click to expand
  1. Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis.
    Infect Immun. 1994 Feb;62(2):596-605 PMID: 8300217
  2. Contribution of the MexXY multidrug transporter to aminoglycoside resistance in Pseudomonas aeruginosa clinical isolates.
    Antimicrob Agents Chemother. 2003 Oct;47(10):3202-7 PMID: 14506031
  3. Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients.
    Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8377-81 PMID: 8378309
  4. A chemosensory system that regulates biofilm formation through modulation of cyclic diguanylate levels.
    Proc Natl Acad Sci U S A. 2005 Oct 4;102(40):14422-7 PMID: 16186483
  5. Contribution of specific Pseudomonas aeruginosa virulence factors to pathogenesis of pneumonia in a neonatal mouse model of infection.
    Infect Immun. 1996 Jan;64(1):37-43 PMID: 8557368
  6. Role of pili in the pathogenesis of Pseudomonas aeruginosa burn infection.
    Microbiol Immunol. 1988;32(2):131-9 PMID: 2897617
  7. An adenylate cyclase-controlled signaling network regulates Pseudomonas aeruginosa virulence in a mouse model of acute pneumonia.
    Infect Immun. 2004 Mar;72(3):1677-84 PMID: 14977975
  8. Role of Pseudomonas aeruginosa PhoP-phoQ in resistance to antimicrobial cationic peptides and aminoglycosides.
    Microbiology (Reading). 2000 Oct;146 ( Pt 10):2543-2554 PMID: 11021929
  9. A re-examination of twitching motility in Pseudomonas aeruginosa.
    Microbiology (Reading). 1999 Oct;145 ( Pt 10):2863-73 PMID: 10537208
  10. GeneMark.hmm: new solutions for gene finding.
    Nucleic Acids Res. 1998 Feb 15;26(4):1107-15 PMID: 9461475
  11. Avirulence and altered physiological properties of cystic fibrosis strains of Pseudomonas aeruginosa.
    Infect Immun. 1985 Nov;50(2):572-6 PMID: 3932213
  12. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis.
    J Infect Dis. 2001 Feb 1;183(3):444-52 PMID: 11133376
  13. Proliferation of mutators in A cell population.
    J Bacteriol. 1997 Jan;179(2):417-22 PMID: 8990293
  14. Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa.
    J Exp Med. 2002 Jul 1;196(1):109-18 PMID: 12093875
  15. Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis.
    J Clin Microbiol. 1987 Oct;25(10):1868-74 PMID: 3117842
  16. Constitutive high expression of chromosomal beta-lactamase in Pseudomonas aeruginosa caused by a new insertion sequence (IS1669) located in ampD.
    Antimicrob Agents Chemother. 2002 Nov;46(11):3406-11 PMID: 12384343
  17. Type III secretion machines: bacterial devices for protein delivery into host cells.
    Science. 1999 May 21;284(5418):1322-8 PMID: 10334981
  18. Characterization of a Pseudomonas aeruginosa efflux pump contributing to aminoglycoside impermeability.
    Antimicrob Agents Chemother. 1999 Dec;43(12):2975-83 PMID: 10582892
  19. Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides.
    Antimicrob Agents Chemother. 1999 Nov;43(11):2624-8 PMID: 10543738
  20. Pyoverdin is essential for virulence of Pseudomonas aeruginosa.
    Infect Immun. 1996 Feb;64(2):518-23 PMID: 8550201
  21. A more sensitive plate assay for detection of protease production by Pseudomanas aeruginosa.
    J Clin Microbiol. 1979 Apr;9(4):538-40 PMID: 110831
  22. A major Pseudomonas aeruginosa clone common to patients and aquatic habitats.
    Appl Environ Microbiol. 1994 Jun;60(6):1734-8 PMID: 8031075
  23. Aminoglycoside antibiotics induce bacterial biofilm formation.
    Nature. 2005 Aug 25;436(7054):1171-5 PMID: 16121184
  24. Predicting deleterious amino acid substitutions.
    Genome Res. 2001 May;11(5):863-74 PMID: 11337480
  25. Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis.
    Dev Cell. 2002 Oct;3(4):593-603 PMID: 12408810
  26. Structure of the autoinducer required for expression of Pseudomonas aeruginosa virulence genes.
    Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):197-201 PMID: 8278364
  27. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection.
    Science. 2000 May 19;288(5469):1251-4 PMID: 10818002
  28. Genome macrorestriction analysis of diversity and variability of Pseudomonas aeruginosa strains infecting cystic fibrosis patients.
    J Clin Microbiol. 1993 Sep;31(9):2320-6 PMID: 8408549
  29. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.
    Microbiol Rev. 1996 Sep;60(3):539-74 PMID: 8840786
  30. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms.
    Nature. 2000 Oct 12;407(6805):762-4 PMID: 11048725
  31. Whole-genome sequence variation among multiple isolates of Pseudomonas aeruginosa.
    J Bacteriol. 2003 Feb;185(4):1316-25 PMID: 12562802
  32. Genetic variation at the O-antigen biosynthetic locus in Pseudomonas aeruginosa.
    J Bacteriol. 2002 Jul;184(13):3614-22 PMID: 12057956
  33. Evaluation of reference dilution test methods for antimicrobial susceptibility testing of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis.
    J Clin Microbiol. 1999 Sep;37(9):2987-91 PMID: 10449487
  34. Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains.
    Infect Immun. 1983 Oct;42(1):170-7 PMID: 6413410
  35. The Bvg virulence control system regulates biofilm formation in Bordetella bronchiseptica.
    J Bacteriol. 2004 Sep;186(17):5692-8 PMID: 15317773
  36. Identification, timing, and signal specificity of Pseudomonas aeruginosa quorum-controlled genes: a transcriptome analysis.
    J Bacteriol. 2003 Apr;185(7):2066-79 PMID: 12644476
  37. Use of siderophores to type pseudomonads: the three Pseudomonas aeruginosa pyoverdine systems.
    Microbiology (Reading). 1997 Jan;143 ( Pt 1):35-43 PMID: 9025276
  38. Mutations in PA3574 (nalD) lead to increased MexAB-OprM expression and multidrug resistance in laboratory and clinical isolates of Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2005 May;49(5):1782-6 PMID: 15855496
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2006-05-30
Epub
2006-00-10
Pages
8487-92
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC1482519
Subset
IM
Grants
NHLBI NIH HHS · K08 HL067903-02 · United States
NHGRI NIH HHS · 5P50 HG 002351 · United States
NHLBI NIH HHS · K08 HL067903 · United States
NHGRI NIH HHS · P50 HG002351 · United States
NIDDK NIH HHS · R01 DK064954 · United States
NHLBI NIH HHS · K08 HL067903-05 · United States
NHLBI NIH HHS · K08 HL067903-01 · United States
NCRR NIH HHS · M01 RR000037 · United States
NHLBI NIH HHS · K08 HL067903-04 · United States
NHLBI NIH HHS · K08 HL067903-03 · United States
NIDDK NIH HHS · 1R01 DK 64954-01A1 · United States
Databases
GENBANK
DQ470842
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]